Latest Posts
About This Stock
More About This Stock
Read
Read
Read
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs, And More
Article By:
Benzinga
Sunday, October 3, 2021 3:45 PM EDT
Biotech stocks came under pressure in the week ending Oct. 1, dragged by broader market weakness and the selling of vaccine stocks. Here are the key catalysts that could move stocks in the unfolding week.
Biotech Bear Market: But Is It Time To Start Trading?
Article By:
Rod Raynovich
Sunday, November 11, 2018 11:31 PM EDT
The Nasdaq is down 1.6% and the Russell 2000 is down 1.8%, killing hopes of a continued Post-Election rally. The biotech sector is for experienced traders only. Healthcare still looks good overall with the XLV down only 0.29% at $92.95.
In this article: IJR, XLV, XBI Also: BMY, MRK, RHHBY, IBB, IMMU, LGND, QQQ, EXEL, NBIX, AMRN, ICPT, ABBV, SRPT, XNCR, LOXO, XLRN, IONS, REGN, CELG, GILD, VRTX, ASH, TSRO
Small Cap Rare Disease Biotechs Jump After Peer Amicus Gets FDA Nod
Article By:
The Fly
Tuesday, July 11, 2017 4:14 PM EDT
Shares of small-cap biotech companies involved in rare disease cures are trading higher after peer Amicus Therapeutics announced that the FDA informed the company that it may now submit an NDA for Fabry disease treatment migalastat.